L2P Research, LLC Announces Acquisition

L2P Research LLC, a leading preclinical CRO, announced Friday that it had completed its acquisition of METIS Research Laboratories headquartered in Ronkonkoma, New York. The Acquisition adds to L2P’s network 5,000 square-foot GLP compliant facility which is focused on providing Radiobinding assays, preclinical toxicology and whole body autoradiograph (QWBA) for innovators of advanced biotherapeutics. METIS Laboratories was founded in 2010 and provides radiotracer services for pharma, biotech, and academic organizations across the world. METIS Laboratories employs one of the oldest methods used for the evaluation of drug molecules, the “Gold Standard”, which is radiometric analysis of lead compounds.

Read the full article: L2P Research, LLC Announces Acquisition //

Source: https://www.businesswire.com/news/home/20200228005498/en/L2P-Research-LLC-Announces-Acquisition

Scroll to Top